By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Domain Therapeutics 



Strasbourg      France
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014 11:30:17 AM
Domain Therapeutics Continues Program To Alter Course Of Parkinson's Disease With Renewed Support By The Michael J. Fox Foundation 4/14/2014 8:34:04 AM
Domain Therapeutics Enters Into Collaboration With XOMA Corporation (XOMA) 2/4/2014 9:28:32 AM
Domain Therapeutics Opens A North American Subsidiary At Montreal's NEOMED Institute 1/20/2014 9:02:19 AM
Domain Therapeutics, Université de Montréal And McGill University Sign New Licensing And Partnership Agreement On G-Protein Coupled Receptor Biosensor Technology 12/18/2013 9:26:38 AM
Domain Therapeutics Grants Prexton Therapeutics an Exclusive Option to License and Develop mGluR4 PAMs for Parkinson's Disease 1/22/2013 11:20:58 AM
Domain Therapeutics Enters Into Collaboration Agreement With Ono Pharmaceutical Company, Ltd. in the Field of GPCR-Based Drug Discovery 10/23/2012 9:47:01 AM
Domain Therapeutics Closes EUR Two Million Funding Round 7/17/2012 12:08:56 PM
Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project 3/13/2012 9:27:59 AM
Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson's Disease 1/30/2012 11:32:55 AM
12
//-->